TY - JOUR
T1 - Novel expression and regulation of gastrin gene in human ovarian cancer cell line, SW626
AU - Kim, Hong Jin
AU - Evers, B. Mark
AU - Banker, Nitesh A.
AU - Greeley, George H.
AU - Hellmich, Mark R.
AU - Thompson, James C.
AU - Townsend, Courtney M.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health (PO1 DK35608, RO1 DK48345, T32 DK06397) , and the James E. Thompson Molecular Biology Laboratory for Surgical Research.
PY - 1998
Y1 - 1998
N2 - Gastrin-secreting tumors have been identified in ectopic locations including the ovary; the mechanisms regulating gastrin gene expression, its distribution, and signaling pathways in these ectopic tissues are not known. The purpose of our present study was to determine: (1) whether the gastrin gene and peptide could be detected in ovarian cancer cell lines, (2) if functional gastrin releasing peptide receptors (GRP-R) are present, and (3) whether gastrin gene expression is altered by GRP. Five ovarian cancer cell lines (SW626, OVCA 420, OVCA 429, OVCA 432, and OVCA 433) were analyzed. We identified gastrin gene and peptide expression in the SW626 cell line but not in the OVCA lines. SW626 cells express a functional GRP-R that is correctly coupled to the Ca2+ signaling pathway. Treatment of SW626 cells with bombesin, the amphibian equivalent of GRP, inhibited expression of the gastrin gene in a time- and dose-dependent fashion. The SW626 ovarian cancer cell line will provide a useful model to further define regulation and expression of both the gastrin gene and peptide in ectopic (nongastrointestinal) tissues.
AB - Gastrin-secreting tumors have been identified in ectopic locations including the ovary; the mechanisms regulating gastrin gene expression, its distribution, and signaling pathways in these ectopic tissues are not known. The purpose of our present study was to determine: (1) whether the gastrin gene and peptide could be detected in ovarian cancer cell lines, (2) if functional gastrin releasing peptide receptors (GRP-R) are present, and (3) whether gastrin gene expression is altered by GRP. Five ovarian cancer cell lines (SW626, OVCA 420, OVCA 429, OVCA 432, and OVCA 433) were analyzed. We identified gastrin gene and peptide expression in the SW626 cell line but not in the OVCA lines. SW626 cells express a functional GRP-R that is correctly coupled to the Ca2+ signaling pathway. Treatment of SW626 cells with bombesin, the amphibian equivalent of GRP, inhibited expression of the gastrin gene in a time- and dose-dependent fashion. The SW626 ovarian cancer cell line will provide a useful model to further define regulation and expression of both the gastrin gene and peptide in ectopic (nongastrointestinal) tissues.
KW - Gastrin
KW - Gastrin releasing peptide
KW - Gene expression
KW - Ovarian cancer
UR - http://www.scopus.com/inward/record.url?scp=0031871982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031871982&partnerID=8YFLogxK
U2 - 10.1023/A:1018846311239
DO - 10.1023/A:1018846311239
M3 - Article
C2 - 9690380
AN - SCOPUS:0031871982
SN - 0163-2116
VL - 43
SP - 1465
EP - 1473
JO - Digestive Diseases and Sciences
JF - Digestive Diseases and Sciences
IS - 7
ER -